Neurocrine Biosciences, Inc. (NBIX)
134.54
+2.15
(+1.62%)
USD |
NASDAQ |
Jan 20, 16:00
133.79
-0.75
(-0.56%)
Pre-Market: 08:30
Neurocrine Biosciences EPS Diluted (Quarterly): 2.044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Masimo Corp. | -1.859 |
| Insulet Corp. | 1.240 |
| Marker Therapeutics, Inc. | -0.1193 |
| CapsoVision, Inc. | -0.1693 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 209.50M |
| Revenue (Quarterly) | 794.90M |
| Total Expenses (Quarterly) | 585.40M |
| Enterprise Value | 12.78B |
| Gross Profit Margin (Quarterly) | 98.24% |
| Profit Margin (Quarterly) | 26.36% |
| Earnings Yield | 3.11% |
| Operating Earnings Yield | 4.03% |
| Normalized Earnings Yield | 3.174 |